Yu Yang Ng - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yu Yang Ng

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Molecular Therapy. Methods & Clinical Development|April 5, 2021

Manufacturing NKG2D CAR-T cells with piggyBac transposon vectors and K562 artificial antigen-presenting cellsJohan C K Tay, Junjian Wang, Zhicheng Du, et al.

Molecular Therapy Oncolytics|May 29, 2020

Electroporation of NKG2D RNA CAR Improves Vγ9Vδ2 T Cell Responses against Human Solid Tumor XenograftsWei Xia Ang, Yu Yang Ng, Lin Xiao, et al.

Biomaterials|January 22, 2025

Non-viral, high throughput genetic engineering of primary immune cells using nanostraw-mediated transfectionArun R K Kumar, Jessalyn Low, Jet Lim, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Molecular Therapy. Methods & Clinical Development|April 5, 2021

Manufacturing NKG2D CAR-T cells with piggyBac transposon vectors and K562 artificial antigen-presenting cellsJohan C K Tay, Junjian Wang, Zhicheng Du, et al.

Molecular Therapy Oncolytics|May 29, 2020

Electroporation of NKG2D RNA CAR Improves Vγ9Vδ2 T Cell Responses against Human Solid Tumor XenograftsWei Xia Ang, Yu Yang Ng, Lin Xiao, et al.

Biomaterials|January 22, 2025

Non-viral, high throughput genetic engineering of primary immune cells using nanostraw-mediated transfectionArun R K Kumar, Jessalyn Low, Jet Lim, et al.

Pageof 2